Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Steroid Resistant Asthma
NCT01210521Phase 2Withdrawn
- Sponsor
- Florida Atlantic University
- Start
- Sep 2010
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 2, open-label, single-arm trial of vitamin d in asthma, sponsored by Florida Atlantic University. Primary endpoint: Pulmonary Function Test at 6 months. Planned start Sep 2010; status: withdrawn.
02
Drugs
vitamin d
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01210521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210521.